Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB)

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 254-259

  Shindo, M ^a   Mullin, G E ^b   Braun Elwert, L ^b   Bergasa, N V ^a   Jones, E A ^c,d   James, S P ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cytokines; Hepatitis B; Liver biopsy; mRNA; Primary biliary cirrhosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MESSENGER RNA;

ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; POLYMERASE CHAIN REACTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 0030017757     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-759.x     Document Type: Article

References (38)

1. James SP, Hoofnagle JH, Strober W et al. Primary biliary cirrhosis: a model autoimmune disease. Ann Intern Med 1983; 99:500-12.
2. Scheuer PJ, Lefkowitch JH. Biliary disease. In: Liver biopsy interpretation, 5th edn. Philadelphia: WB Saunders, 1994:38-61.
3. James SP, Elson CO, Jones EA et al. Abnormal regulation of immunoglobulin synthesis in vitro in primary biliary cirrhosis. Gastroenterology 1980; 79:242-52.
4. James SP, Jones EA, Hoofnagle JH et al. Circulating activated B cells in primary biliary cirrhosis. J Clin Immunol 1985; 5:254-60.
5. + T cells have abnormal activation and suppressor function in vitro. Hepatology 1989; 10: 408-13.
6. Bjorkland A, Festin R, Mendel-Hartvig I et al. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology 1991; 13:1106-11.
7. Hashimoto E, Lindor KD, Homburger HA et al. Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc 1993; 68: 1049-55.
8. + T cells bearing Leu-8 homing receptor in primary biliary cirrhosis. Phorbol myristate acetate enhances T-cell function. Dig Dis Sci 1994; 39:1329-36.
9. + T cells and B cell-expression of Leu-8 antigen in peripheral blood of patients with primary biliary cirrhosis. Hepato-Gastroenterol 1994; 41:239-43.
10. - T cell subsets defined by isoforms of CD45 in primary biliary cirrhosis. Clin Exp Immunol 1995; 99:233-9.
11. Dudley FJ, Fox RA, Sherlock S. Cellular immunity and hepatitis-associated (Australia) antigen liver disease. Lancet 1972; i:723-6.
12. Liles WC, van Voorhis WC. Nomenclature and biological significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995; 172:1573-80.
13. Jilbert AR, Burrell CJ, Gowans EJ et al. Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue. Hepatology 1986; 6:645-7.
14. Civeira M, Prieto J, Morte S et al. Interleukins in chronic active hepatitis B: relationship with viral markers. J Hepatol 1987; 5:37-44.
15. Muller C, Knoflach P, Zielinski CC. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease. Hepatology 1989; 10:928-32.
16. Anastassakos C, Alexander GJ, Wolstencroft RA et al. Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection. Gastroenterology 1989; 94:999-1005.
17. Inoue M, Katumu S, Yoshioka K et al. Hepatitis B core antigenspecific IFN-gamma production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J Immunol 1989; 142:4006-11.
18. Kakumu S, Yoshioka K, Tsutumi Y et al. Production of tumor necrosis factor, interleukin 1, and interferon-gamma by peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Clin Immunol Immunopathol 1990; 56:54-65.
19. Nouri-Aria KT, Arnold J, Daavison F et al. Hepatic interferon-alpha gene transcripts and products in liver specimens from acute and chronic hepatitis B virus infection. Hepatology 1991; 13:1029-34.
20. Sheron N, Lau J, Daniels H et al. Increased production of tumor necrosis factor alpha in chronic hepatitis B infection. J Hepatol 1991; 12:241-5.
21. Miller LC, Kaplan MM. Serum interleukin-2 and tumor necrosis factor-alpha in primary biliary cirrhosis: decrease by colchicine and relationship to HLA-DR4. Am J Gastroenterol 1992; 87:465-70.
22. Broome U, Eriksson LS, Sundin U et al. Decreased in vitro production of tumor necrosis factor in primary biliary cirrhosis. Scand J Gastroenterol 1992; 27:124-8.
23. Fong T-L, Shindo M, Feinstone SM et al. Detection of replicative form of HCV in livers and serum from patients with chronic hepatitis C. J Clin Invest 1991; 88:1058-60.
24. Wang AM, Doyle MV, Mark DF. Quantitation of mRNA by the polymerase chain reaction. Proc Natl Acad Sci USA 1989; 86:9717-9.
25. Gilliland G, Perrin S, Blanchard K et al. Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction. Proc Natl Acad Sci USA 1990; 87: 2725-8.
26. Mullin GE, Lazenby AJ, Harris ML et al. Increased IL-2 mRNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992; 102:1620-7.
27. Tovey MG. Expression of the gene of interferons and other cytokines in normal and diseased tissues of man. Experimentia 1989; 45:526-34.
28. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990; 86:1790-8.
29. Martinez OM, Villanueva JC, Gershwin ME, Krams SM. Cytokine patterns and cytotoxic mediators in primary biliary cirrhosis. Hepatology 1995; 21:113-9.
30. Tsai SL, Lai MY, Chen DS. Analysis or rearranged T cell receptor (TCR) Vβ transcripts in livers of primary biliary cirrhosis: preferential Vβ usage suggests antigen-driven selection. Clin Exp Immunol 1996; 103:99-104.
31. Suzuki Y, Orrelana MA, Schreiber RD et al. Interferon-gamma: major mediator of resistance against Toxoplasma gondii. Science 1988; 240:516-8.
32. Steiniger B, Falk P, van der Meide PH. Interferon-gamma in vivo. Induction and loss of class II MHC antigens and immature myelomonocytic cells in rat organs. Eur J Immunol 1988; 18:661-5.
33. Steiniger B, van der Meide PH, Westermann J et al. Systemic induction of class II MHC antigens after continuous intravenous infusion of recombinant gamma interferon in rats. Transplant Proc 1987; 19:4322-6.
34. Ballardini G, Mirakian R, Bianchi F et al. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: relevance to pathogenesis. N Engl J Med 1984; 2:1009-13.
35. Saidman S, Duquesnoy RJ, Zeevi A et al. Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lympocytes. Hepatology 1991; 13: 239-46.
36. Tsuneyama K, van de Water J, Leung PSC et al. Abnormal expression of the E2 component of the pyruvate dehydrogenase complex on the luminal surface of biliary epithelium occurs before major histocompatibility complex class II and BB1/B7 expression. Hepatology 1995; 21:1031-7
37. Kaplan MM, Knox TA. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate. Gastroenterology 1991; 101:1332-8.
38. Poupon RE, Poupon R, Balkau B et al. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994; 330: 1342-7.